Human papillomavirus in lung carcinomas among three Latin American countries

Oncology Reports

Volumn 15, Issue 4, 2006, Pages 883-888

  Castillo, Andres ^a   Aguayo, Francisco ^a   Koriyama, Chihaya ^a   Shuyama, Karem ^a   Akiba, Suminori ^a   Herrera Goepfert, Roberto ^b   Carrascal, Edwin ^c   Klinge, German ^d   Sánchez, Juvenal ^d   Eizuru, Yoshito ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^c UNIVERSIDAD DEL VALLE   (Colombia)

^d Laboratorio Regional   (Peru)

Author keywords

HPV; Latin America; Lung cancer

Indexed keywords

PROTEIN P16INK4A; PROTEIN P53; TP53 PROTEIN, HUMAN; VIRUS DNA;

ADENOCARCINOMA; AGED; ARTICLE; CHEMISTRY; COLOMBIA; DNA SEQUENCE; FEMALE; GENETICS; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; LUNG TUMOR; MALE; METABOLISM; MEXICO; MIDDLE AGED; PAPILLOMA VIRUS; PATHOLOGY; PERU; SEX DIFFERENCE; SMALL CELL CARCINOMA; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; VIROLOGY; VIRUS GENOME; VIRUS INFECTION;

ADENOCARCINOMA; AGED; BLOTTING, SOUTHERN; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; COLOMBIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; GENOME, VIRAL; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MEXICO; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PERU; SEQUENCE ANALYSIS, DNA; SEX FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33746438585     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.4.883     Document Type: Article

References (26)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummler JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer world wide. J Pathol 189: 12-19, 1999. (Pubitemid 29406813)
2. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R and Shah KV: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796-802, 1995.
3. Bosch FX, Lorincz A, Munoz N, Meijer C and Shah KV: The causal relationship between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265, 2002. (Pubitemid 34293391)
4. Snijders P, van den Brule A, Meijer C and Walboomers J: HPV and cancer of the aerodigestive tract. Papillomavirus Rep 6: 157-162, 1995.
5. Markham AF: Carcinoma of the lung: warts and all. Thorax 51: 878-879, 1996.
6. Gillison ML and Shan KV: Role of Mucosal Human Papillomavirus in Non-genital Cancers. J Natl Cancer Inst Monographs 31: 57-65, 2003.
7. IARC World Cancer Report. Stewart BW and Kleihaus P (eds). IARC Press, Lyon, 2003.
8. Syrjänen KJ: Condylomatous changes in neoplastic bronchial epithelium. Report of a case. Respiration 38: 229-304, 1979.
9. Syrjänen KJ: Epithelial lesions suggestive of a condylomatous origin found closely associated with invasive bronchial squamous cell carcinoma. Respiration 49: 150-160, 1980.
10. Syrjänen KJ: HPV infections and lung cancer. J Clin Pathol 55: 885-891, 2002.
11. Miyagi J, Tsuhako K, Kinjo T, Iwamawa T and Hirayasu T: Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung I Okinawa: a subtropical island in Southern Japan. J Clin Pathol 53: 676-684, 2000.
12. Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY, Su JM and Lee H: The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 61: 2799-2803, 2001.
13. Aguayo F, Meneses M. Corvalán A, Muñoz M, Koriyama C, Eizuru Y and Akiba S: Identification of human papillomavirus 16 (HPV 16) in keratinizing lung carcinoma. Rev Chil Enferm Respire 18: 83-89, 2002.
14. Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ and Walboomers JM: The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 71: 173-181, 1990. (Pubitemid 20046022)
15. De Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ and Snijders PJ: The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76: 1057-1062, 1995.
16. Ralhan R, Mathew R, Arora S, Bahl R, Shukla NK and Mathur M: Frequent alterations in the expression of tumor suppressor genes p16INK4A and pRb in esophageal squamous cell carcinoma in the Indian population. J Cancer Res Clin Oncol 126: 655-660, 2000.
17. Xu H, Lu DW, El-Mofty SK and Wang HL: Metachronous squamous cell carcinomas evolving from independent oropharyngeal and pulmonary squamous papilomas: association with human papillomavirus 11 and lack of aberrant p53, Rb, and p16 protein expression. Hum Pathol 35: 1419-1422, 2004. (Pubitemid 39601584)
18. Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, Vaccarella SV, Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi SF and Ojeda JM: Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 13: 2271-2276, 2004. (Pubitemid 40054329)
19. Chiou HL, Wu MF, Liaw YC, Cheng YW, Wong RH, Chen JT, Chen CY and Lee H: The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer 97: 1558-1563, 2003.
20. Howley PM and Lowy DR: Papillomavirus and their replication. In: Fields Virology. Knipe DM and Howley PM (eds). Lipppincott Williams & Wilkins, Tokyo, pp2197-2229, 2001.
21. Barbosa MS: The oncogenic role of Human Papillomavirus Proteins. Crit Rev Oncogen 7: 1-18, 1996.
22. Soini Y, Kamel KN, Pollanen R, Vahakangas K, Lehto V and Paako P: Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma. Thorax 51: 887-893, 1996. (Pubitemid 26289027)
23. Khleif SN, deGregori J, Yee C, Otterson GA, Kaye FJ, Nevins JR and Howley PM: Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA 93: 4350-4354, 1996.
24. Sano T, Oyama T, Kashiwabara K, Fukuda T and Nakajima T: Expression status of p16 protein is associated with human papillomavirus oncongenic potential in cervical a genital lesions. Am J Pathol 153: 1741-1748, 1998. (Pubitemid 28550662)
25. Kim K, Garner-Hamrick PA, Fisher C, Lee D and Lambert PF: Methylation pattern of papillomavirus DNA, its influence on E2 function, and implication in viral infection. J Virol 77: 12450-12459, 2003. (Pubitemid 37430642)
26. Wu MF, Cheng YW, Lai JC, Hsu MC, Chen JT, Liu WS, Chou MC, Chen CY and Lee H: Frequent p16INK4a promoter hypermethylation in human papillomavirus- infected female lung cancer in Taiwan. Int J Cancer 113: 440-445, 2005. Technology Technology